AIM ImmunoTech Approves Large Issuances and Reverse Stock Split Option

What Happened
AIM ImmunoTech Inc. (AIM) held a Special Meeting of stockholders on July 15, 2026 and filed an 8-K reporting the results. With 27,724,245 shares outstanding as of the record date, about 38.5% (10,671,690 shares) were represented at the meeting, meeting the 33 1/3% quorum requirement. Stockholders approved five proposals to permit the issuance of more than 19.99% of the company’s common stock in connection with the exercise of various warrants and conversions/repayments of promissory notes, and they approved a proposal giving the board the option to effect a reverse stock split at a ratio up to 1-for-25.

Key Details

• Meeting date and filings: Special Meeting on July 15, 2026; definitive proxy filed June 25, 2026.
• Approvals to allow issuances >19.99% under NYSE American rules (Sections 713(a) & 713(b)) for:
  • Class H warrant exercise (warrant inducement letter dated May 7, 2026) — Vote: For 2,677,035; Against 1,312,258; Abstain 149,248; Broker non-votes 6,533,150.
  • Class I warrants (securities purchase agreement dated May 20, 2026) — Vote: For 2,676,038; Against 1,317,709; Abstain 144,794; Broker non-votes 6,533,150.
  • Class J warrants (securities purchase agreement dated June 9, 2026) — Vote: For 2,684,308; Against 1,301,624; Abstain 152,610; Broker non-votes 6,533,150.
  • Conversion/repayment of promissory note dated Feb 16, 2024 — Vote: For 2,676,665; Against 1,309,155; Abstain 152,722; Broker non-votes 6,533,150.
  • Conversion/repayment of promissory note dated Nov 18, 2025 — Vote: For 2,673,399; Against 1,312,327; Abstain 152,816; Broker non-votes 6,533,150.
• Reverse stock split option: Shareholders approved alternate amendments allowing the Board to implement a reverse split at a ratio up to 1-for-25. Vote reported: For 7,344,727; Against 3,315,347; Abstain 11,616.
• Adjournment authority: Proposal to permit adjournment for further solicitation if needed was also approved (For 7,380,255; Against 2,938,798; Abstain 352,637).

Why It Matters

• These approvals clear the way for potentially large share issuances if warrants are exercised or notes are converted, which could dilute existing shareholders by more than 19.99% if fully used.
• The reverse split authorization (up to 1-for-25) gives the board flexibility to consolidate shares — a move often used to increase the per-share trading price or comply with listing standards on the NYSE American.
• Investors should watch follow-up disclosures about actual warrant exercises, note conversions, or a board decision to implement a reverse split, since those actions would change share count, ownership percentages, and per-share metrics.